Organon (FRA:7XP) Total Liabilities : €12,061 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Organon Total Liabilities?

Organon's Total Liabilities for the quarter that ended in Dec. 2024 was €12,061 Mil.

Organon's quarterly Total Liabilities declined from Jun. 2024 (€11,157.29 Mil) to Sep. 2024 (€11,045.36 Mil) but then increased from Sep. 2024 (€11,045.36 Mil) to Dec. 2024 (€12,060.70 Mil).

Organon's annual Total Liabilities declined from Dec. 2022 (€11,183.57 Mil) to Dec. 2023 (€11,121.38 Mil) but then increased from Dec. 2023 (€11,121.38 Mil) to Dec. 2024 (€12,060.70 Mil).

Organon Total Liabilities Historical Data

The historical data trend for Organon's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Total Liabilities Chart

Organon Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

3,800.11

10,787.27

11,183.57

11,121.38

12,060.70

Organon Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															11,121.38	10,895.56	11,157.29	11,045.36	12,060.70

Organon Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Organon's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2595.69	+	(8461.3	+	933.035
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	70.67	+	0	+	0)
	=	12,061

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	12511.455	-	450.76
	=	12,061

Organon's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2595.69	+	(8461.3	+	933.035
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	70.67	+	0	+	0)
	=	12,061

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	12511.455	-	450.76
	=	12,061

Organon Total Liabilities Related Terms

Thank you for viewing the detailed overview of Organon's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

OGN:USA OGN:Mexico 1OGN:Italy 0A9W:UK 7XP:Germany

Address

30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302

Website

https://www.organon.com

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon Headlines

No Headlines